Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 118292-40-3 | Product Number: T3108
Tazarotene
Purity: >98.0%(GC)
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
10MG |
$75.00
|
3 | 1 | 8 |
|
100MG |
$437.00
|
2 | 3 | 32 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | T3108 |
Purity / Analysis Method | >98.0%(GC) |
Molecular Formula / Molecular Weight | C__2__1H__2__1NO__2S = 351.46 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 10MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 118292-40-3 |
Reaxys Registry Number | 8159145 |
PubChem Substance ID | 253662270 |
Merck Index (14) | 9081 |
MDL Number | MFCD00867628 |
Appearance | White to Yellow to Green powder to crystal |
Purity(GC) | min. 98.0 % |
Melting point | 102.0 to 106.0 °C |
Melting Point | 105 °C |
Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
RTECS# | US5675100 |
HS Number | 2934.99.3000 |
References
- Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin
- Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin
- Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene
- Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis (a review)
- Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.